Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=collection%3ACTG&lookfor=%22Lopinavir%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=collection%3ACTG&lookfor=%22Lopinavir%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=collection%3ACTG&lookfor=%22Lopinavir%22&type=Subject
PubPharm (10)
1
Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks: a prospective, open-label, randomized controlled trial : Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks : a prospect
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks: a prospective, open-label, randomized controlled trial : Virological response of switching tenofovir disoproxil fumarate(TDF)-based regimen to abacavir(ABC)-based regimen versus lopinavir/ritonavir(LPV/r) plus lamivudine(3TC) in HIV-infected patients with TDF-induced nephrotoxicity at 24 weeks : a prospect
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 : The Regimen of Favipiravir Plus Hydroxychloroquine Can Accelerate Recovery of the COVID-19 Patients With Moderate Severity in Comparison to Lopinavir/Ritonavir Plus Hydroxychloroquine Regimen: an Open-label, Non-randomized Clinical Trial Study
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
4
Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg : Pharmacokinetic and Efficacy of Saquinavir Mesylate Film Coated Tablet / Ritonavir 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg Once Daily in HIV Pretreated Patients
enthalten in:
ClinicalTrials.gov
| 2015
Wird geladen...
5
Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole : A Phase 1, Open-Label, Parallel Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Multiple Doses of Lopinavir/Ritonavir and the Effects of Lopinavir/Ritonavir on the Pharmacokinetics of Multiple Doses of Isavuconazole in Healthy Adult Subjects
enthalten in:
ClinicalTrials.gov
| 2015
Wird geladen...
6
Estudio Fase 3, Aleatorizado, Abierto, Controlado de Lopinavir/Ritonavir y Lamivudina versus terapia estándar en Pacientes Infectados con HIV-1 Naïve. - GARDEL : Estudio Fase 3, Aleatorizado, Abierto, Controlado de Lopinavir/Ritonavir y Lamivudina versus terapia estándar en Pacientes Infectados con HIV-1 Naïve. - GARDEL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2014
Wird geladen...
7
Estudio Fase 3, Aleatorizado, Abierto, Controlado de Lopinavir/Ritonavir y Lamivudina versus terapia estándar en Pacientes Infectados con HIV-1 Naïve. - GARDEL : Estudio Fase 3, Aleatorizado, Abierto, Controlado de Lopinavir/Ritonavir y Lamivudina versus terapia estándar en Pacientes Infectados con HIV-1 Naïve. - GARDEL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2014
Wird geladen...
8
Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure : A Randomized Controlled Study Compares the 48 Weeks Results of HIV-1 RNA Between Ritonavir-boosted Lopinavir Monotherapy and Ritonavir-boosted Lopinavir + Optimized Background Regimens in HIV-1 Infected Patients Who Have HIV-1 RNA <50 Copies/ml More Than 6 Months While Receiving Salvage PI-based Regimen and Previously Failed NNRTI-based Regimen
enthalten in:
ClinicalTrials.gov
| 2013
Wird geladen...
9
A Phase IIb, 96 week, randomized, open-label, multicenter,parallel group, repeat dose study to evaluate the safety,tolerability, pharmacokinetics and antiviral effect of differentdoses and regimens of GW873140 in combination with Kaletra(lopinavir and ritonavir) in HIV-1 infected antiretroviral therapynaive subjects : A Phase IIb, 96 week, randomized, open-label, multicenter,parallel group, repeat dose study to evaluate the safety,tolerability, pharmacokinetics and antiviral effect of differentdoses and regimens of GW873140 in combination with Kaletra(lopinavir and ritonavir) in HIV-1 infected antiretroviral therapynaive subjects
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
10
A Phase IIb, 96 week, randomized, open-label, multicenter,parallel group, repeat dose study to evaluate the safety,tolerability, pharmacokinetics and antiviral effect of differentdoses and regimens of GW873140 in combination with Kaletra(lopinavir and ritonavir) in HIV-1 infected antiretroviral therapynaive subjects : A Phase IIb, 96 week, randomized, open-label, multicenter,parallel group, repeat dose study to evaluate the safety,tolerability, pharmacokinetics and antiviral effect of differentdoses and regimens of GW873140 in combination with Kaletra(lopinavir and ritonavir) in HIV-1 infected antiretroviral therapynaive subjects
enthalten in:
WHO International Clinical Trials Registry Platform
| 2012
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Medienart: E-Ressourcen
Medienart
10
Aufsätze
10
E-Artikel
E-Ressourcen
Zeitschriftentitel
6
WHO International Clinical Trials Registry Plat...
4
ClinicalTrials.gov
Thema
10
610
10
Study Type: Interventional
5
Recruitment Status: Completed
4
Recruitment Status: Not yet recruiting
2
Medical Condition: El propósito del estudio es...
2
Medical Condition: GW873140 in combination with...
2
Medical Condition: Tenofovir disoproxil fumarat...
2
Phase: Phase 3
1
Medical Condition: COVID-19, Favipiravir, Kalet...
1
Medical Condition: HIV, AIDS, Lopinavir, Treatm...
1
Medical Condition: Pharmacokinetics of Isavucon...
1
Medical Condition: Saquinavir/Ritonavir BID or ...
1
Phase: Phase 1
1
Phase: Phase 2/Phase 3
1
Phase: Phase 4
1
Recruitment Status: Withdrawn
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2020-
7
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...